Skip to main navigation
Codiak Biosciences

Investor Relations - Top Nav

  • Our Science

    Our Science

    Through our proprietary engEx™ Platform, we are harnessing the power of nature’s intercellular communication system to engineer a new class of medicines, exosome therapeutics.

    • Exosomes Explained
    • engEx™ Platform
    • Targeted Administration
    • Publications & Presentations
  • Manufacturing
  • Pipeline & Programs

    Pipeline & Programs

    We are utilizing our engEx™ Platform to build a broad pipeline of therapeutic candidates that we believe can have a transformative impact on the treatment of a broad spectrum of diseases, with an initial focus on oncology and neurology.

    • Pipeline
    • exoSTING™
    • exoIL-12™
    • exoASO-STAT6™
  • About Us

    About Us

    At Codiak, we are working to create a major shift in the development of tomorrow’s medicines through scientific ambition, remarkable ingenuity and determined passion for improving patients’ lives.

    • Our Mission
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Careers
  • Investors & Media

    Investors & Media

    Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines.

    • Overview
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • Investor Resources

Events

Upcoming Events
May 11, 2023
Inaugural EF Hutton Global Conference
Past Events
November 30, 2022
5th Annual Evercore ISI HealthCONx Conference
August 10, 2022 at 2:20 PM EDT
Wedbush PacGrow Healthcare Conference 2022
August 9, 2022
BTIG Biotechnology Conference 2022
June 30, 2022 at 8:00 AM EDT
Codiak BioSciences exoIL-12 and exoSTING Clinical Update
February 18, 2022 at 2:00 PM EST
Data from Preclinical Program of exoASO-STAT6 Published in Science Advances
January 10, 2022 at 7:00 AM EST
H.C. Wainwright BioConnect 2022 Conference
December 2, 2021 at 12:10 PM EST
4th Annual Evercore ISI HealthCONx Conference
November 16, 2021 at 8:00 AM EST
Codiak BioSciences exoSTING Phase 1/2 Data Readout
June 10, 2021 at 3:00 PM EDT
Goldman Sachs 42nd Annual Global Healthcare Conference

Join our team of experts working at the forefront of advancing engineered exosomes. Explore Careers

© 2023 All Rights Reserved.

Footer Links

  • Contact
  • Privacy Policy
  • Terms of Use
LinkedIn Twitter